Squarepoint’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-183,262
| Closed | -$231K | – | 2758 |
|
|
2024
Q4 | $231K | Buy |
183,262
+37,159
| +25% | +$46.8K | ﹤0.01% | 2321 |
|
|
2024
Q3 | $275K | Buy |
146,103
+98,007
| +204% | +$184K | ﹤0.01% | 2048 |
|
|
2024
Q2 | $356K | Buy |
+48,096
| New | +$356K | ﹤0.01% | 1886 |
|
|
2023
Q3 | – | Sell |
-10,285
| Closed | -$76.3K | – | 2449 |
|
|
2023
Q2 | $76.3K | Sell |
10,285
-18,860
| -65% | -$140K | ﹤0.01% | 2246 |
|
|
2023
Q1 | $275K | Buy |
+29,145
| New | +$275K | ﹤0.01% | 1725 |
|
|
2020
Q3 | – | Sell |
-16,188
| Closed | -$171K | – | 2319 |
|
|
2020
Q2 | $171K | Buy |
+16,188
| New | +$171K | ﹤0.01% | 1799 |
|
|
2019
Q3 | – | Sell |
-757
| Closed | -$6K | – | 2226 |
|
|
2019
Q2 | $6K | Sell |
757
-80
| -10% | -$634 | ﹤0.01% | 2251 |
|
|
2019
Q1 | $12K | Hold |
837
| – | – | ﹤0.01% | 2045 |
|
|
2018
Q4 | $10K | Sell |
837
-1,703
| -67% | -$20.3K | ﹤0.01% | 1870 |
|
|
2018
Q3 | $57K | Buy |
2,540
+1,797
| +242% | +$40.3K | ﹤0.01% | 1912 |
|
|
2018
Q2 | $14K | Buy |
+743
| New | +$14K | ﹤0.01% | 1710 |
|
|
2015
Q3 | – | Sell |
-1,737
| Closed | -$138K | – | 405 |
|
|
2015
Q2 | $138K | Buy |
+1,737
| New | +$138K | 0.04% | 388 |
|